Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HPGD | P15428 | 2/20 | 0.62 |
| ▸ | NPC1 | O15118 | 1/20 | 0.62 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.62 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.62 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.62 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.62 |
| ▸ | RAB9A | P51151 | 1/20 | 0.62 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.62 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.54 |
| ▸ | MDM2 | Q00987 | 1/20 | 0.53 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.53 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.53 |
| ▸ | ROCK2 | O75116 | 4/20 | 0.51 |
| ▸ | ROCK1 | Q13464 | 4/20 | 0.51 |
| ▸ | LMNA | P02545 | 3/20 | 0.51 |
| ▸ | BCHE | P06276 | 1/20 | 0.51 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.51 |
| ▸ | TP53 | P04637 | 1/20 | 0.51 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.51 |
| ▸ | POLB | P06746 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15143918 | 0.86 | SMN1; SMN2 (0.79) | HPGDNPC1CYP1A2CYP2D6CYP2C9 | |
| Propham SCHEMBL67344 | 0.81 | SMN1; SMN2 (0.66) | HPGDNPC1CYP1A2CYP2D6CYP2C9 | |
| Propham SCHEMBL8536412 | 0.81 | SMN1; SMN2 (0.66) | HPGDNPC1CYP1A2CYP2D6CYP2C9 | |
| SCHEMBL1616693 | 0.80 | MDM2 (0.61) | HPGDSMN1; SMN2KDM4EMDM2L3MBTL1 | |
| SCHEMBL967222 | 0.80 | RAB9A (0.58) | HPGDNPC1RAB9ASMN1; SMN2KDM4E | |
| SCHEMBL10192163 | 0.79 | NPC1 (0.69) | HPGDNPC1CYP1A2CYP2D6CYP2C9 | |
| Propham SCHEMBL28077800 | 0.79 | SMN1; SMN2 (0.64) | HPGDNPC1CYP1A2CYP2D6CYP2C9 | |
| SCHEMBL2637743 | 0.78 | HPGD (0.61) | HPGDNPC1CYP1A2CYP2D6CYP2C9 | |
| SCHEMBL9335595 | 0.78 | HPGD (0.67) | HPGDNPC1CYP1A2CYP2D6CYP2C9 | |
| SCHEMBL2188393 | 0.78 | SMN1; SMN2 (0.67) | HPGDNPC1CYP1A2CYP2D6CYP2C9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 35 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230058178-A1 | METHODS AND MATERIALS FOR TREATING NERVE INJURY AND/OR PROMOTING WOUND HEALING | UNITED STATES GOVERNMENT | 2023-02-23 | — | — | US | claimed |
| WO-2021150773-A1 | METHODS AND MATERIALS FOR TREATING NERVE INJURY AND/OR PROMOTING WOUND HEALING | THE PENN STATE RESEARCH FOUNDATION (US) | 2021-07-29 | — | — | WO | claimed |
| CN-103209695-A | Azabenzothiazole compounds, compositions and methods of use | HOFFMANN LA ROCHE | 2013-07-17 | — | — | CN | claimed |
| CN-1745064-A | Pyridines for the treatment of damaged mammalian neural tissue | PURDUE RESEARCH FOUNDATION (US) | 2006-03-08 | — | — | CN | claimed |
| WO-2024151969-A1 | POTASSIUM CHANNEL BLOCKERS OR DERIVATIVES THEREOF FOR PREVENTING, ALLEVIATING, AND/OR TREATING MORBIDITY AND MORTALITY INDUCED BY PATHOGENS OR OTHER INDUCERS OF IMMUNE EXHAUSTION AND/OR EXCESS IMMUNE ACTIVATION | UNIVERSITY OF ROCHESTER (US) | 2024-07-18 | — | — | WO | disclosed |
| EP-3355925-B1 | TREATMENT OF ACUTE TRAUMATIC INJURY | UNIV ROCHESTER (US) | 2024-02-28 | — | — | EP | disclosed |
| US-20240058312-A1 | METHODS AND MATERIALS FOR TREATING BONE LOSS | THE PENN STATE RESEARCH FOUNDATION | 2024-02-22 | — | — | US | disclosed |
| US-20240024216-A1 | METHODS AND MATERIALS FOR TREATING HAIR LOSS | THE PENN STATE RESEARCH FOUNDATION | 2024-01-25 | — | — | US | disclosed |
| WO-2024011220-A1 | POTASSIUM CHANNEL BLOCKERS OR DERIVATIVES THEREOF FOR PREVENTING, ALLEVIATING, AND/OR TREATING TISSUE DYSFUNCTION CAUSED BY TOXIC INSULTS | UNIVERSITY OF ROCHESTER (US) | 2024-01-11 | — | — | WO | disclosed |
| EP-4274546-A1 | METHODS AND MATERIALS FOR TREATING HAIR LOSS | THE PENN STATE RESEARCH FOUNDATION (US) | 2023-11-15 | — | — | EP | disclosed |
| EP-4274551-A1 | METHODS AND MATERIALS FOR TREATING BONE LOSS | THE PENN STATE RESEARCH FOUNDATION (US) | 2023-11-15 | — | — | EP | disclosed |
| US-20230346758-A1 | 4-AMINOPYRIDINE (4-AP) AND BONE MORPHOGENETIC PROTEIN 2 (BMP-2) | THE PENN STATE RESEARCH FOUNDATION | 2023-11-02 | — | — | US | disclosed |
| US-8299051-B2 | Beta-lactamase inhibitory compounds | SOUTHERN METHODIST UNIVERSITY (US) | 2012-10-30 | — | — | US | disclosed |
| US-8097638-B2 | Pyridines for treating injured mammalian nerve tissue | PURDUE RESEARCH FOUNDATION (US) | 2012-01-17 | — | — | US | disclosed |
| US-20100009954-A1 | BETA-LACTAMASE INHIBITORY COMPOUNDS | SOUTHERN METHODIST UNIVERSITY | 2010-01-14 | — | — | US | disclosed |
| US-20100009954-A1 | BETA-LACTAMASE INHIBITORY COMPOUNDS | SOUTHERN METHODIST UNIVERSITY | 2010-01-14 | — | — | US | disclosed |
| EP-1567497-B1 | PYRIDINES FOR TREATING INJURED MAMMALIAN NERVE TISSUE | PURDUE RESEARCH FOUNDATION (US) | 2009-09-23 | — | — | EP | disclosed |
| US-20090118295-A1 | CHEMICAL COMPOUNDS | SYNGENTA CROP PROTECTION, INC (US) | 2009-05-07 | — | — | US | disclosed |
| US-20080039490-A1 | PYRIDINES FOR TREATING INJURED MAMMALIAN NERVE TISSUE | PURDUE RESEARCH FOUNDATION (US) | 2008-02-14 | — | — | US | disclosed |
| CN-1745064-A | Pyridines for the treatment of damaged mammalian neural tissue | PURDUE RESEARCH FOUNDATION (US) | 2006-03-08 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230346758-A1 | 4-AMINOPYRIDINE (4-AP) AND BONE MORPHOGENETIC PROTEIN 2 (BMP-2) | BMP4, BMP2, BMP1 | HPGD 2101/4885NPC1 4252/4885CYP1A2 4107/4885 |
| US-20240058312-A1 | METHODS AND MATERIALS FOR TREATING BONE LOSS | BMP4, ACP3, COL2A1 | HPGD 839/4885NPC1 3354/4885CYP1A2 4428/4885 |
| US-20080039490-A1 | PYRIDINES FOR TREATING INJURED MAMMALIAN NERVE TISSUE | P2RY4, INA, PMP22 | HPGD 1256/4885NPC1 4768/4885CYP1A2 2426/4885 |
| US-20240024216-A1 | METHODS AND MATERIALS FOR TREATING HAIR LOSS | BMP4, S100A4, S100B | HPGD 502/4885NPC1 4300/4885CYP1A2 3497/4885 |
| US-20090118295-A1 | CHEMICAL COMPOUNDS | MRM1, MNS1, CHRM1 | HPGD 4257/4885NPC1 1763/4885CYP1A2 509/4885 |
| US-20100009954-A1 | BETA-LACTAMASE INHIBITORY COMPOUNDS | MGAM, GUSB, LCT | HPGD 376/4885NPC1 3009/4885CYP1A2 878/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.